最近のもの

Nagayama I, Takayanagi K, Hasegawa H, Maeshima A. Tubule-Derived Follistatin Is Increased in the Urine of Rats with Renal Ischemia and Reflects the Severity of Acute Tubular Damage. Cells 4;12:801, 2023.

Haruguchi H, Suemitsu K, Isogai N, Murakami M, Fujihara M, Iwadoh K, Menk J, Ookubo H, Ogawa T. IN.PACT AV access randomized trial: Japan cohort outcomes through 12 months.. Ther Apher Dial 2023 Jan 6.

Sato S, Takayanagi K, Shimizu T, Kanozawa K, Iwashita T, Hasegawa H. Correlation between albuminuria and interstitial injury marker reductions associated with SGLT2 inhibitor treatment in diabetic patients with renal dysfunction. Eur J Med Res 27:140, 2022.

Nagayama I, Maeshima A, Nagata D. Urinary Activin A: A Novel Biomarker for Human Acute Kidney Injury. Diagnostics (Basel) 12:661, 2022.

Ryohei Yamamoto· Enyu Imai · Shoichi Maruyama· Hitoshi Yokoyama · Hitoshi Sugiyama · Asami Takeda · Tatsuo Tsukamoto · Shunya Uchida · Kazuhiko Tsuruya · Tatsuya Shoji · Hiroki Hayashi · Yasuhiro Akai · Megumu Fukunaga · Tsuneo Konta · Saori Nishio · Shunsuke Goto · Hirofumi Tamai · Kojiro Nagai · Ritsuko Katafuchi · Kosuke Masutani · Takashi Wada · Tomoya Nishino · Arimasa Shirasaki · Hiroshi Sobajima · Kosaku Nitta · Kunihiro Yamagata · Junichiro J. Kazama · Keiju Hiromura ·
Hideo Yasuda · Makoto Mizutani · Toshiyuki Akahori · Tomohiko Naruse33 · Takeyuki Hiramatsu ·Kunio Morozumi · Tetsushi Mimura · Yosuke Saka · Eiji Ishimura · Hajime Hasegawa · Daisuke Ichikawa · Takashi Shigematsu · Hiroshi Sato · Ichiei Narita · Yoshitaka Isaka on behalf of the Japan Nephrotic Syndrome Cohort Study investigators. Time to remission of proteinuria and incidence of relapse in patients with steroid‐sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study. Clin Exp Nephrol 35:1135-1144, 2022.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, Uchida S, Tsukamoto T, Tsuruya K, Akai Y, Nitta K, Fukunaga M, Hayashi H, Masutani K, Wada T, Konta T, Katafuchi R, Nishio S, Goto S, Tamai H, Shirasaki A, Shoji T, Nagai K, Nishino T, Yamagata K, Kazama JJ, Hiromura K, Yasuda H, Mizutani M, Naruse T, Hiramatsu T, Morozumi K, Sobajima H, Saka Y, Ishimura E, Ichikawa D, Shigematsu T, Sofue T, Fujimoto S, Ito T, Sato H, Narita I, Isaka Y. Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study. Sci Rep. 13;12:9782, 2022.

Ogawa T, Inamura M, Kawai Y, Yamamoto R, Yasuda K, Shimizu T, Tamaru JI, Hasegawa H. Difficulty removing dialysis cuff catheter after its adhesion to the right atrium. J Vasc Access 23:467-470, 2021.

Akiyama Y, Matsuoka R, Masuda T, Iwamoto S, Sugie S, Muto T, Miyamoto Y, Ohdate T, Nakagawa S, Okada M, Imai T, Komada T, Suzuki M, Maeshima A, Akimoto T, Saito O, Nagata D. Comparative Impact of Isolated Ultrafiltration and Hemodialysis on Fluid Distribution: A Bioimpedance Study. Blood Purif Aug 31:1-11, 2021.

Oishi Y, Ikeuchi H, Hamatani H, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Iwase A, Hiromura K. Pregnancy outcomes in patients with systemic lupus erythematosus with or without a history of lupus nephritis. Clin Exp Nephrol 2021 25(8):835-843.

Chieko Hirota, Yui Takashina, Yuta Yoshino, Hajime Hasegawa, Ema Okamoto, Toshiyuki Matsunaga and Akira Ikari. Reactive Oxygen Species Downregulate Transient Receptor Potential Melastatin 6 Expression Mediated by the Elevation of miR-24-3p in Renal Tubular Epithelial Cells. Cells 2021, 11:1893.

Ogawa T, Kanayama Y, Sasaki Y,Tokui K, Hara H, Iwashita T, Shimizu T, Hasegawa H. Assessment of an automatic hot water sterilizing system-equipped dialysis supply device's circuit degradation, 7 years post-installment. ASAIO J In press 2021.

Ogawa T, Inamura M, Kawai Y, Yamamoto R, Yasuda K, Shimizu T, Tamaru J, Hasegawa H. Difficulty removing dialysis cuff catheter after its adhesion to the right atrium. J Vasc Access In press 2021.

Yokoyama H., Yamamoto R., Imai E., Maruyama S., Nitta K., Tsukamoto T., Uchida S., Takeda A., Sato T., Wada T., Hayashi H., Akai Y., Fukunaga M., Tsuruya K., Masutani K., Konta K., Konta T., Shoji T., Hiramatsu T., Goto S., Tamai H., Nishio S., Shirasaki A., Nagai K., Yamagata K., Hasegawa H., Yasuda H., Ichida S., Naruse T., Fukami K., Nishino T., Sobajima H., Tanaka S., Akahori T., Ito T., Terada Y., Katafuchi R., Okada H., Ishimura E., Kasama J., Hiromura K., Mimura T., Suzuki H., Saka Y., Sofue T., Suzuki Y., Shibagaki Y., Kitagawa K., Morozumi K., Fujita Y., Mizutani M., Shigematsu T., Furuichi K., Fujimoto K., Sato H., Matsuo S., Narita I., Isaka Y. Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol 2020, Oct 24, 893-909.

Marunaka K, Fujii N, Kimura T, Furuta T, Hasegawa H, Matsunaga T, Endo S, and Ikari A. Rescue of tight junctional localization of a claudin-16 mutant D97S by antimalarial medicine primaquine in Madin-Darby canine kidney cells. Scientific Rep 9 (1): 9647, 2019 2019.

Shimizu T, Takayanagi K, Iwashita T, Ikari A, Anzai N, Okazaki S, Hara H, Hatano M, Sano T, Ogawa T, Kanozawa K and Hasegawa H Down-regulation of magnesium transporting molecule, claudin-16, as a possible cause of hypermagnesiuria with the development of tubulo-interstitial nephropathy. Magnesium Res 31(1):11-23, 2018.

Kanozawa K, Noguchi Y, Sugahara S, Nakamura S, Yamamoto H, Kaneko K, Kono R, Sato S, Ogawa T, Hasegawa H, Katayama S The Renoprotective Effect and Safety of a DPP-4 Inhibitor, Sitagliptin, at a Small Dose in Type 2 Diabetic Patients with a Renal Dysfunction when Changed from Other DPP-4 Inhibitors: REAL Trial. Clin Exp Nephrol 22: 825-834, 2018.

Hara H, Nakamura Y, Hatano M, Iwashita T, Shimizu T, Ogawa T, Kanozawa K, and Hasegawa H. Protein energy wasting and sarcopenia in dialysis patients. Contribut Nephrol 196: 243-249, 2018.

Shimizu T, Terao M, Hara H, Iwashita T, Ogawa T, Kanozawa K, and Hasegawa H. Dysnatremia in renal failure. Contribut Nephrol 196: 229-236, 2018.

Ogawa T, Yoshino H, Sasaki Y, Kanayama Y, Sano T, Kogure Y, Kanozawa K, and Hasegawa H. Our approaches for selective plasma exchange. Contribut Nephrol 196: 194-199, 2018.

Sasaki Y, Ogawa T, Kanayama Y, Tokui K, Morita T, Yasuda K, Okada Y, Hara K, Shimizu T, and Hasegawa H. Current methods we use for home hemodialysis management. Contribut Nephrol 196: 237-242, 2018.

Kato S, Ishibashi1 A, Sugiura K, Kani K, Ogawa T, Hasegawa H, Yakabi K. Changes in treatment with granulocyte and monocyte adsorptive apheresis from the past to future in patients with inflammatory bowel disease.Contribut Nephrol 196: 200-208, 2018.

Takashina Y, Manabe A, Hasegawa H, Matsunaga T, Endo S, Ikari A. Sodium Citrate Increases Expression and flux of Mg2+ Transport Carriers Mediated by Activation of MEK/ERK/c-Fos Pathway in Renal Tubular Epithelial Cells. Nutrients 10:1345-1361, 2018.

Manabe, A, Furukawa, C, Hasegawa, H, Matsunaga, T, Endo, S, Ikari, A. Up-regulation of transient receptor potential melastatin 6 channel expression by rosiglitazone and all-trans-retinoic acid in erlotinib-treated renal tubular epithelial cells. J Cell Physiol. 234:8951-8962, 2018.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study Clin Exp Nephrol 22: 1266-1280, 2018.

Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, Yuzawa Y, Okada H, Koya D, Kiyomoto H, Shibagaki Y, Matsuda K, Kato A, Hayashi T, Ogawa T, Tsukamoto T, Noiri E, Negi S, Kamei K, Kitayama H, Kashihara N, Moriyama T, Terada Y.Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee.Clin Exp Nephrol.22(5):985-1045, 2018.

Hasegawa H. Clinical Assessment of Warfarin Therapy in Patients with Maintenance Dialysis-clinical Efficacy, Risks and Development of Calciphylaxis. Ann Vascular Diseases 10: 1-8, 2017.

Nitta K, Masakane I, Tomo T, Tsuchida K, Ikeda K, Ogawa T, Kanda E, Kanno Y, Komatsu Y, Taniguchi M, Taki F, Hasegawa T, Hanafusa N, Hamano T, Fukagawa M, Minakuchi J, Yamamoto H, Washida N, Wada T, Watanabe Y. Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy. Renal Replacement Therapy 24: 501-510, 2017.

Marunaka K, Furukawa C, Fujii N, Kimura T, Furuta T, Matsunaga T, Endo S, Hasegawa H, Anzai N, Yamazaki Y, Yamaguchi M, and Ikari A. The RING Finger- and PDZ Domain-Containing Protein PDZRN3 Controls Localization of the Mg2+ Regulator Claudin-16 in Renal Tube Epithelial Cells. J Biol Chem 292:13034-13044, 2017.

Furukawa C, Fujiia N, Matsunaga T, Endoa S, Hasegawa H, Ito Y, Yamaguchi M, Yamazaki Y, and Ikari A. Up-regulation of transient receptor potential melastatin 6 channel expression by tumor necrosis factor-α in the presence of epidermal growth factor receptor tyrosine kinase inhibitor. J Chem Physics 232:2842-2850, 2017.

Yasuda K, Iwashita T, Tayama Y, Makino Y, Watanabe A, Sano T, Shimizu T, Ogawa T, Kanozawa K, and Hasegawa H. Severe hyponatremia in a patient with schizophrenia associated with prolonged consciousness disturbance. Clin Exp Nephrol Case Rep 6:5-11, 2017.→[PubMed]

Ogawa T, Sasaki Y, Kanayama Y, Yasuda K, Okada Y, Kogure Y, Sano T, Hatano M, Hara H, Kanozawa K, Hasegawa H. Evaluation of the functions of the temporary catheter with various tip types.Hemodial Int, Suppl 2 :S10-S15, 2017

Yamagata K, Makino H, Iseki K, Ito S, Kimura K, Kusano E, Shibata T, Tomita K, Narita I, Nishino T, Fujigaki Y, Mitarai T, Watanabe T, Wada T, Nakamura T, Matsuo S; Study Group for Frontier of Renal Outcome Modifications in Japan (FROM-J). Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial. PLoS One 11: e0151422 2016.

Takayanagi K, Shimizu T, Tayama Y, Ikari A, Anzai N, Iwashita T, Asakura J, Hayashi K, Mitarai T, and Hasegawa H. Down-regulation of transient receptor potential (TRP) M6 channel as a cause of hypermagnesiuric hypomagnesemia in obese type-2 diabetic rats. Am J Physiol 308 (12):F1386-97, 2015. 　→[PubMed]

Ogawa T, Matsuda A, Kanayama Y, Sasaki Y, Harada E, Tanabe A, Yasuda K, Okada Y, Sano T, ShimizuT, Tayama Y, and Hasegawa H. How to monitor vascular access in our hospital. J Vasc Access 2015 16 Suppl 10: 50-2　→[PubMed]

Noiri C, Shimizu T, Takayanagi K, Tayama Y, Iwashita T, Okazaki S, Hatano M, Matsumura O, Kato H, Matsuda A, and Hasegawa H. Clinical significance of fractional magnesium excretion (FEMg) as a predictor of interstitial nephropathy and its correlation with conventional parameters. Clin Exp Nephrol 19 (6): 1071-8, 2015 　→[PubMed]

Ogawa T, Harada E, Kanayama Y, Tanabe A, Inamura M, Kiba T, Shimizu T, Iwashita T, Tayama Y, Matsuda A, and Hasegawa H. The impact of buttonhole cannulation on patients and staff in hemodialysis facilities. Contribut Nephrol 2015 186: 13-20　→[PubMed]

Onizawa N, Iseki T, Hori T, Otani N, Ouchi M, Hayashi K, Hasegawa H, Anzai N. Interaction of zotepine and chlorprothixene with URAT1-mediated urate transport. Gout and Nucleic Acid Metabolism 2015 39 (2): 147-153　→[PubMed]

Matsuda A, Kitaoka T, and Suzuki H. Effect of Hemoglobin Target on Progression of Chronic Kidney Disease. J Nephrol Therapeutic S1-006; February 25, 2014.　→[PubMed]

Ikari A, Tonegawa C, Sanada A, Kimura T, Yamaguchi M, Yamazaki Y, Hasegawa H, Endo S, Matsunaga T, and Sugatani J. Tight junctional localization of claudin-16 is regulated by syntaxin 8 in renal tubular epithelial cells. J Biol Chem 289:13112-13123, 2014.　→[PubMed]

Kono R, Kanozawa K, Shimosawa T, Tayama Y, Matsuda A, Hasegawa H, Mitarai T. Adrenomedullin in peritoneal effluent expressed by peritoneal mesothelial cells. Clin Exp Nephrol 18(1):124-129, 2014.　→[PubMed]

Kuragano T, Matsumura O, Matsuda A, Hara T, Kiyomoto H, Murata T, Kitamura K, Fujimoto S, Hase H, Joki N, Fukatsu A, Inoue T, Itakura I, Nakanishi T. Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients. Kidney Int 86(4):845-54, 2014.　→[PubMed]

Kawamura T, Yoshimura M, Miyazaki Y, Okamoto H, Kimura K, Hirano K, Matsushima M, Utsunomiya Y, Ogura M, Yokoo T, Okonogi H, Ishii T, Hamaguchi A, Ueda H, Furusu A, Horikoshi S, Suzuki Y, Shibata T, Yasuda T, Shirai S, Imasawa T, Kanozawa K, Wada A, Yamaji I, Miura N, Imai H, Kasai K, Soma J, Fujimoto S, Matsuo S, and Tomino Y. The Special IgA Nephropathy Study Group. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy. Nephrol Dial Transplant 29 (8): 1546-1553, 2014.　→[PubMed]

Hasegawa H, Tayama Y, Takayanagi K, Asakura J, Nakamura T, Kawashima K, Shimizu T, Iwashita T, Ogawa T, Matsuda A, and Mitarai T. Release From Glomerular Overload by the Addition of Low-dose Thiazide in Patients With Angiotensin Receptor Blocker-Resistant Hypertension. Kidney and Blood Pres Res 2013;37:1-9, 2013　→[PubMed]

Asakura J, Hasegawa H, Takayanagi K, Shimazu T, Suge R, Shimizu T, Iwashita T, Tayama Y, Matsuda A, Kanozawa K, Araki N and Mitarai T. Renoprotective effect of pioglitazone by the prevention of glomerular hyperfiltration through the possible restoration of altered macula densa signaling in rats with type-2 diabetic nephropathy. Nephron Exp Nephrol 122(3-4) 83-94, 2013　→[PubMed]

Hasegawa H, Kanozawa K, Asakura J, Takayanagi K, Komuro O, Fukada H, Tokushima H, Kogure H, Matsuzawa M, and Mitarai T. Significance of estimated salt excretion as a possible predictor of the efficacy of concomitant angiotensin receptor blocker (ARB) and low-dose thiazide in patients with ARB-resistance. Hypertens Res 36 (9): 776-782, 2013.　→[PubMed]

Tayama Y, Hasegawa H, Takayanagi K, Matsuda A, Shimizu T, Asakura K, Iwashita T, Ogawa T, Katoh H, and Mitarai T. Prevention of lipopolysaccharide-induced peritoneal damage by eplerenone in rats undergoing peritoneal dialysis. J Nephrol 26 (6): 1160-1190, 2013　→[PubMed]

Kurosawa T, Nagasawa H, Nishi E, Takei H, Okuyama A, Kondo T, Nishimura K, Sakai R, Shibata A, Chino K, Ogawa H, Ito T, Amano K, and Kato H. Successful treatment of class IV + V lupus nephritis with combination therapy of high dose corticosteroids, tacrolims and intravenous cyclophosphamide. Intern Med 52: 1125-1130, 2013　→[PubMed]

Yamashiro M, Hasegawa H, Matsuda A, Kinoshita M, Matsumura O, Isoda I, and Mitarai T. A case of water intoxication caused by excessive water drinking as a game penalty. Case Rep Nephrol Urol 3: 147-152, 2013.　→[PubMed]

Hara H, Hasegawa H, Iwanaga M, Ogawa T, Matsuda A, Kanozawa K, Kato H, and Mitarai T. A case of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with lupus erythematosus in the central nervous system. Clin Exp Nephrol Case Rep 2:17-22, 2013.　→[PubMed]

Ogawa T, Matsuda A, Yamaguchi Y, Sasaki Y, Kanayama Y, Maeda T, Noiri C, Hasegawa H, Matsumura O, and Mitarai T. Dialysate purification after introduction of automated hot water disinfection system to central dialysis fluid delivery system. ASAIO J. 58:127-31. 2012.　→[PubMed]

Suge R, Shimazu T, Hasegawa H, Inoue I, Hayashibe H, Nagasaka H, Araki N, Katayama S, Nomura M, and Watanabe S. Cerebral antioxidant enzyme increase associated with learning deficit in type 2 diabetes rats. Brain Res. 1481:97-106. 2012.　→[PubMed]

Ogawa T, Murakawa M, Matsuda A, Kanozawa K, Kato H, Hasegawa H, and Mitarai T. Endogenous factors modified by hemodialysis may interfere with the accuracy of blood glucose-measuring device. Hemodial Int. 16:266-73. 2012.　→[PubMed]